KAIROS PHARMA, LTD. (KAPA) Operating cash flow 2023–2025
KAIROS PHARMA, LTD. (KAPA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.4MFY2025 · since FY2023: $81,000 → -$3.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.4M | +13.0% |
| FY2024 | -$4.0M | -4982.7% |
| FY2023 | $81,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice